CVR 44861429Private limited company (ApS)Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)Secondary industries: Detailhandel med andre fødevarer (472700)HerlevFounded 29 May 2024
CVR holds no employment figures for this company.
Compiled by Dandex from the Danish Business Registry (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Dandex is Danish Company Data. Connect it once and ask about MetaSolutions ApS, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Set up DandexEmployees
1
Annual report 2025, average
Gross profit
-33.3K
DKK, annual report 2025
Result
-39.8K
DKK, annual report 2025
Equity
-9.2K
DKK, annual report 2025
Metaceutic ApSCVR 40638350, 100% of capital and votes
Ali Kazemi Sereshtsince 29 May 2024
Owners of 5% or more. CVR registers shares in bands, not exact figures.
CVR 40638350100% of capital and votessince 29 May 2024
Ultimate controller
Holding in A. Kazemi ApS, since 1 Jul 2019
Holding company
CVR 40626263Private limited company (ApS)
Holding in Metaceutic ApS, since 17 May 2021
Holding company
CVR 40638350Private limited company (ApS)
Holding in MetaSolutions ApS, since 29 May 2024
This company
MetaSolutions ApS
CVR 44861429
Decided by Dandex from CVR and the filed annual reports, not registered by the company.
Fixed rules decide most of these. The auditor's report, the business model, the revenue model and the activity in its own words are read by a calibrated decision model from the report's text and the purpose clause. Each label links to its definition.
CVR records founders at incorporation. It does not record whether they are alive or still involved.
The company's own figures, in DKK, from the annual reports filed in XBRL.
2025, DKK: Gross profit -33.3K, Operating profit -33.3K, Result for the year -39.8K
Arrow keys move through the years, Home and End go to the first and the latest, Escape returns to the latest.
2025, DKK: Total assets 263.4K, Equity -9.2K
Arrow keys move through the years, Home and End go to the first and the latest, Escape returns to the latest.
| DKK thousands | 2024 | 2025 |
|---|---|---|
| Gross profit | -6 | -33 |
| Operating profit | -6 | -33 |
| Result for the year | -9 | -40 |
| Equity | 31 | -9 |
| Total assets | 34 | 263 |
| Employees (average) | 0 | 1 |
| Credit metrics (Dandex calculations) | ||
| EBITDA / gross profit (EBITDA i procent af bruttofortjenesten)Pro: EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) is in the Pro plan, see pricingEBITDA as a share of gross profit. | Pro: EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) is in the Pro plan, see pricingEBITDA as a share of gross profit. | |
| Employee growth (vækst i antal ansatte) | Not reportednote 1 | 0% |
| Net interest-bearing debt (NIBD, nettorentebærende gæld)Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. | Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. | |
| Gearing, NIBD / EBITDAPro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. | Pro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. | |
| Interest coverage (rentedækning)Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. | Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. | |
| Adjusted equity ratio (justeret soliditetsgrad)Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. | Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. | |
| ROIC (afkast af investeret kapital)Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. | Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. | |
| Capex % of sales (investeringer i procent af omsætningen)Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. | Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. | |
| FCFF / EBITDA (pengestrømskonvertering)Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. | Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. | |
Not every period is a full year: 2024 covers 7 months (29 May to 31 Dec 2024). Changes against it compare periods of different length.
Credit metrics are Dandex calculations, not filed values; grey figures are estimates with a note. Definitions. Revenue-based rows are empty: the company reports gross profit only (bruttofortjeneste), which class B filers may.
How each credit metric is calculated:
Pro: Signals (signaler) are in the Pro plan, see pricingChanges worth a look, raised from the registry and new annual reports.
New leadership (nyt lederskab), New company (ny virksomhed), Ownership change (ejerskifte), Relocation (flytning), Growth surge (vækstspurt), Headcount decline (nedgang i ansatte), Restructuring (omstrukturering), Industry change (brancheskift), Board change (bestyrelsesændring), Dissolution (ophør), Distress warning (risikoadvarsel), Fund investment (fondsinvestering), Fund exit (fondsexit), Fund board seat (fondsbestyrelsespost).
What Pro holds for MetaSolutions ApS:
Have Pro? Sign in.
Amounts in DKK. Cash price is per DKK 1 of nominal capital, which a share split does not move.
| Date | Change | Cash price | Paid in | Implied value | Capital after |
|---|---|---|---|---|---|
| FoundingCashPaid in 46,920, cash price 1.17 | 1.17 | 46,920 | None | 40,000 |
Source: Erhvervsstyrelsen's announcements, shown where the amounts add up to the registered capital.
Source: CVR, read 17 Nov 2026.
Counts include corrections, and an audit firm that re-registered under a new entity.
Source: CVR, read 17 Nov 2026.
5 registrations, as published by Erhvervsstyrelsen. People's street addresses are cut to postcode and city.
Ny adresse: c/o Metaceutic ApS, Lyskær 8B, st., 2730 Herlev
Ny kommune: Herlev
Vedtægter ændret: 01.07.2026
Nyt navn: MetaSolutions ApS
Ny adresse: c/o Metaceutic ApS, Mileparken 22, 2740 Skovlunde
Nyt binavn: Premind ApS
Vedtægter ændret: 11.02.2026
Ny adresse: c/o Metaceutic ApS, Mileparken 22, 2., 2740 Skovlunde
Ny kommune: Ballerup
Stiftelsesdato: 29.05.2024.
Virkningsdato: 29.05.2024.
Seneste vedtægtsdato: 29.05.2024.
Kapital:
kr. 40.000,00.
Kapitalklasser: Nej
Indbetalingsmåde: Indbetalt kontant kr. 40.000,00 til kurs 117,30, fuldt indbetalt.
Stifter:
CVR-NR. 40638350 Metaceutic ApS, Vandtårnsvej 62A, 2860 Søborg, den 29.05.2024.
Direktion:
Ali Kazemi Seresht, den 29.05.2024.
Selskabet tegnes af en direktør.
Første regnskabsår:
29.05.2024 - 31.12.2024.
Regnskabsår:
01.01 - 31.12.
Formål:
Selskabets formål er udvikling og salg af naturprodukter.
P-number 1030394778Lyskær 8, 2730 Herlev